Cell therapy for treatment of cancer

This white paper provides the current position on the key cell types and their role in cancer immunotherapies, with a more in-depth focus on chimeric antigen receptor (CAR) T-cell therapies. This will include a review of toxicity management guidelines for CAR T-cell therapies, the future outlook on improving safety and efficacy profiles, current CAR T cell limitations and potential use for solid tumors.